{
    "organizations": [],
    "uuid": "26e78c6ac274b0967d036aedbba645380ea5469a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-astellas-pharma-acquires-universal/brief-astellas-pharma-acquires-universal-cells-idUSL4N1Q41CD",
    "ord_in_thread": 0,
    "title": "Astellas Pharma acquires Universal Cells",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Astellas Pharma Inc\n* Says it has acquired Universal Cells Inc., and will pay up to $102.5 million of upfront and milestones to acquire 100 percent ownership of Universal Cells depending on achievement of certain specified clinical milestones\nSource text in Japanese: goo.gl/ui5yFj\nFurther company coverage: (Beijing Headline News)\n ",
    "published": "2018-02-14T09:39:00.000+02:00",
    "crawled": "2018-02-14T12:19:54.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "astellas",
        "pharma",
        "inc",
        "say",
        "acquired",
        "universal",
        "cell",
        "pay",
        "million",
        "upfront",
        "milestone",
        "acquire",
        "percent",
        "ownership",
        "universal",
        "cell",
        "depending",
        "achievement",
        "certain",
        "specified",
        "clinical",
        "milestone",
        "source",
        "text",
        "japanese",
        "company",
        "coverage",
        "beijing",
        "headline",
        "news"
    ]
}